Detall de la convocatòria

Expressió d'interès - Expression of interest

Característiques

Característica
Objectiu de la convocatòria
  • To support randomised, interventional and pragmatic comparative-effectiveness multi-country Investigator-Initiated Clinical Studies (IICS).
  • To encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct comparative-effectiveness multi-country IICS.
    • Característiques principals
  • Be a pragmatic comparative effectiveness trial, designed as randomised interventional trial.
  • They shall consider healthcare interventions
  • These interventions shall have high public relevance only in the fields of these specific diseases or conditions (that are of equal importance):
  • Cardiovascular diseases
  • Metabolic disorders
  • Nutrition and lifestyle-related diseases
  • Non-communicable respiratory diseases
    • Lloc de presentació
    El personal de l'HMRIB i PSMAR que necessiteu més informació adreceu-vos a:
    Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@researchmar.net Ext.: 1670
    Marta López: mlopez4@researchmar.net Ext.: 1576
    Convocatòria (URL)
    https://era4health.eu/calls/effectrial2025.php
    Requisits
    Applicants must demonstrate that the research team contains the necessary breadth and depth of expertise in all the methodological areas required to deliver the proposed study.
    PIs should demonstrate experience and expertise in the conduct and delivery of clinical trials
    Furthermore, additional aspects need to be considered in the application:
  • The design of the clinical study (sample collection, statistical power, interpretation, relevant models for hypothesis validation) must be well justified and should be part of the proposal.
  • Strategies for recruitment, retention, assessment, and analysis must be included. The clinical study design and objectives should take into consideration the population that would be needed to reach the objective of the study.
  • Gender equality as well as inclusiveness of the diversity of the population in the recruitment. Involvement of patient/patients' representatives and other relevant users in the co-creation and implementation of the tasks.
    Please take in note that clinical studies conducted for direct commercial purposes are excluded from support by the ERA4Health programme.
    • Dotació
    3.000.000€
    Durada
    48 months

    Arxius

    Arxiu
    ERA4Health_Call Text_EffecTrial.pdf
    ERA4Health_Template_Pre-proposal_application_form_EffecTrial.docx
    ERA4Health_Guideline_for_Applicants_EffecTrial.pdf